Soleno Therapeutics Inc (SLNO) — Cash Flow Quality Index
Soleno Therapeutics Inc (SLNO) has a Cash Flow Quality Index of 0.83x as of March 2026. Operating cash flow of $25.98 Million is below net income of $31.38 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore SLNO long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Soleno Therapeutics Inc Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Soleno Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Soleno Therapeutics Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Soleno Therapeutics Inc (2025–2025)
Year-by-year earnings quality comparison for Soleno Therapeutics Inc. For live market cap and the full company financial profile, see market value of Soleno Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.24x | $46.80 Million | $20.89 Million | — |